The Dawn of a New Era of PE Therapy : A Sunrise Pulmonary Embolism Symposium

Wednesday, May 22, 2019: 6:45 AM-7:45 AM
Castellana Ballroom 2 (The Cosmopolitan of Las Vegas)

Supported By: Boston Scientific, EKOS, a BTG International Company, Actelion Pharmaceuticals US, Inc., Cook Medical and Abiomed.

Sponsored By:

The Pulmonary Embolism Response Team Consortium (PERT) was developed as a multi-disciplinary approach to the prevention, management, and treatment of pulmonary embolism (PE). The PERT Consortium™ intends to guide and influence PE care and research in institutions across the U.S. to increase survival rates and the future of PE treatment. The PERT Consortium™ intends to guide and influence PE care and research throughout domestic and international institutions and will be the driving force behind increased survival rates and the future of PE treatment.
6:45 AM
Welcome and Introduction
Kenneth Rosenfield, M.D., MHCDS, MSCAI, Massachusetts General Hospital; Andrew J. Klein, M.D., FSCAI, Piedmont Heart Institute
6:47 AM
Catheter-Directed Therapy for PE: EKOS vs. Standard Infusion Catheter: What Is the Best for Your Patient!
Gregory Piazza, M.D., Brigham And Women's Hospital
6:55 AM
Massive and Submassive PE: When Do You Stop Therapy?
Andrew J. Klein, M.D., FSCAI, Piedmont Heart Institute
7:03 AM
Alternatives to CDT
Thomas M Tu, M.D., Louisville Cardiology Medical Group
7:11 AM
Massive PE: ECMO, Lysis, CDT or Embolectomy. When and What?
Mahir Elder, M.D., FSCAI, Heart & Vascular Institute
7:19 AM
You had a PE…Now What?
Wissam Jaber, M.D., Emory Heart & Vascular Center
7:27 AM
BPA for CTEPH: Who Should Be Doing This?
Ehtisham Mahmud, M.D., FSCAI, University of California, San Diego Sulpizio Cardiovascular Center
7:35 AM
Question and Panel Discussion
See more of: Satellite Sessions
<< Previous Satellite | Next Satellite >>